Zobrazeno 1 - 10
of 31
pro vyhledávání: '"L. J. Eron"'
Autor:
Leonard Harry Goldberg, R. H. Kaufman, R. L. Batenhorst, T. O. Kurtz, L. J. Eron, G. S. Boone, Marcus A. Conant
Publikováno v:
Journal of Medical Virology. 41:45-50
This study presents data relative to the efficacy and safety following the continuous use of oral acyclovir in the treatment of genital herpes over a 5-year period. In this study, 1,146 patients (53% males; 47% females) were originally enrolled. Thes
Autor:
David Fedorczyk, Mark Lebwohl, Jack Mendelson, Virginia Chen, L. J. Eron, J. Richard Trout, John M. Douglas, James D. Connor, Marcus A. Conant, Terry F. Plasse, Stephen L. Sacks, Steven Marlowe, Patricia Bradstreet
Publikováno v:
Antiviral Research. 17:235-243
Topical recombinant alpha-2 interferon treatment of recurrent genital herpes was studied in a randomized, double-blind, placebo controlled clinical trial. Three hundred and eighty-seven patients were treated at eight study centers with either interfe
Autor:
Raoul E. Benveniste, R W Hill, K Nagashima, L J Eron, U M Csaikl, M A Gonda, Louis E. Henderson, W B Knott, Raymond C. Sowder
Publikováno v:
Journal of Medical Primatology. 19:351-366
Single-cell clones of HIV-1 (FRE-3) or SIV/Mne infected HuT 78 cells were obtained by plating dilutions of virally infected HuT 78 cells on a monolayer of sheep choroid plexus cells in 96-well microtiter plates. Several of these clones produce HIV-1
Publikováno v:
Sexually Transmitted Infections. 69:91-93
OBJECTIVE--To determine whether interferon alpha-2a, when utilised as adjuvant chemotherapy following ablation of condylomata acuminata (genital warts) by cryotherapy, is effective in the prevention of recurrences. DESIGN--Randomised, placebo-control
Publikováno v:
Sexually Transmitted Diseases. 18:41-43
One hundred thirty-seven evaluable patients with uncomplicated gonorrhea were treated with a single 500-mg intramuscular dose of cefotaxime. All isolates were susceptible to concentrations of cefotaxime less than or equal to 0.1 microgram/ml. The min
Publikováno v:
Archives of dermatology. 129(5)
This multicenter trial (19 sites) was initiated in 1984 in more than 1100 immunocompetent individuals with a history of frequently recurring genital herpes (mean,or = 12 episodes per year). The first year of this suppressive therapy trial was placebo
Autor:
R E, Benveniste, R W, Hill, L J, Eron, U M, Csaikl, W B, Knott, L E, Henderson, R C, Sowder, K, Nagashima, M A, Gonda
Publikováno v:
Journal of medical primatology. 19(3-4)
Single-cell clones of HIV-1 (FRE-3) or SIV/Mne infected HuT 78 cells were obtained by plating dilutions of virally infected HuT 78 cells on a monolayer of sheep choroid plexus cells in 96-well microtiter plates. Several of these clones produce HIV-1
Autor:
Kathy A. Schmitt, L. J. Eron, Mary L. Owens, David Baker, Andrina J. Hougham, Alex Ferenczy, Libby Edwards, Terry L. Fox
Publikováno v:
Archives of Dermatology. 134:25
Objective To compare the safety and effectiveness of 5% and 1% imiquimod cream with vehicle cream in the treatment of external anogenital warts. Design Randomized, double-blind, placebo-controlled comparison that evaluated patients for total clearanc
Autor:
Gloria S. Boone, Leonard Harry Goldberg, L. J. Eron, Randal L. Batenhorst, Marcus A. Conant, T. O. Kurtz, Raymond H. Kaufman
Publikováno v:
Archives of Dermatology. 129:582
• Background and Design.— This multicenter trial (19 sites) was initiated in 1984 in more than 1100 immunocompetent individuals with a history of frequently recurring genital herpes (mean, ≥12 episodes per year). The first year of this suppress
Publikováno v:
Antimicrobial Agents and Chemotherapy. 31:1137-1139
Ninety-four patients with recurrences of genital herpes were randomized in a double-blind trial to receive topical therapy for 5 days with either alpha-2a interferon at 30 X 10(6) IU/ml or 10 X 10(6) IU/ml or placebo six times daily. No differences w